GoalVest Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.6K Buy
591
+122
+26% +$11.9K 0.01% 225
2026
Q2
$48.5K Buy
469
+61
+15% +$5.45K 0.01% 214
2026
Q1
$29.3K Hold
408
– – 0.01% 284
2025
Q4
$32.4K Buy
+408
New +$32.2K 0.01% 286
2025
Q2
– Sell
-6
Closed -$407 – 405
2025
Q1
$407 Sell
6
-171
-97% -$10.2K ﹤0.01% 380
2024
Q4
$7.95K Buy
+177
New +$9.93K ﹤0.01% 292
2024
Q1
– Sell
-48
Closed -$3.79K – 424
2023
Q4
$3.79K Buy
48
+40
+500% +$2.85K ﹤0.01% 300
2023
Q3
$559 Buy
+8
New +$567 ﹤0.01% 455
2022
Q2
– Sell
-16
Closed -$2K – 355
2022
Q1
$2K Buy
+16
New +$1.68K ﹤0.01% 287

Other funds holding CVS

GoalVest Advisory's CVS Position: Q3 2026 in Review

GoalVest Advisory increased its CVS Health (CVS) stake by 26% in Q3 2026, buying an estimated $11.9K and bringing the position to 591 shares worth $50.6K. The position accounts for 0.01% of the portfolio, ranked #225.

GoalVest Advisory first reported a position in CVS in Q1 2022 and has held it in 9 quarters since. 70 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • GoalVest Advisory held 591 shares of CVS Health worth $50.6K as of Q3 2026.
  • GoalVest Advisory bought 122 CVS Health shares in Q3 2026, an estimated $11.9K.
  • CVS Health made up 0.01% of GoalVest Advisory's portfolio in Q3 2026, its #225 holding.
  • GoalVest Advisory first reported a position in CVS Health in Q1 2022 and has held it in 9 quarters since.
  • 70 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on GoalVest Advisory's 13F filing for Q3 2026, filed 2 Oct 2026.